MedTrace Logo

A DirEct to PatieNt Study in Chronic Pain

NCT05515341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2026-05-13

No results posted yet for this study

Summary

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

Conditions

Interventions

DEVICE

Commercially Approved Interventional Medical Device/Therapy for Chronic Pain

Commercially Approved Interventional Medical Device/Therapy

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Natalie B Lyons · Boston Scientific Corporation

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-10
Primary Completion
2026-05-11
Completion
2026-05-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05515341 on ClinicalTrials.gov